BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6465620)

  • 1. Changes in the rheologic properties of blood after a high altitude expedition.
    Palareti G; Coccheri S; Poggi M; Tricarico MG; Magelli M; Cavazzuti F
    Angiology; 1984 Jul; 35(7):451-8. PubMed ID: 6465620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pentoxifylline on pulmonary hemodynamics during acute hypoxia in anesthetized dogs.
    Chick TW; Scotto P; Icenogle MV; Sikes CW; Doyle MP; Riedel CE; Wood SC; Loeppky JA
    Am Rev Respir Dis; 1988 May; 137(5):1099-103. PubMed ID: 3195808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pentoxifylline on hemorheologic alterations induced by incremental treadmill exercise in thoroughbreds.
    Weiss DJ; Geor RJ; Burger K
    Am J Vet Res; 1996 Sep; 57(9):1364-8. PubMed ID: 8874734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
    Ott E; Lechner H; Fazekas F
    Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
    Aviado DM; Dettelbach HR
    Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemorheology in surgery--a review.
    Müller R; Musikić P
    Angiology; 1987 Aug; 38(8):581-92. PubMed ID: 3307545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.
    Schneider R; Schmid-Schönbein H; Kiesewetter H
    Eur Neurol; 1983; 22 Suppl 1():98-104. PubMed ID: 6884407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results.
    Seiffge D; Berthold R; Berthold F
    Klin Wochenschr; 1983 Nov; 61(22):1159-60. PubMed ID: 6656178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
    Perego MA; Sergio G; Artale F; Giunti P; Danese C
    Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication.
    Rao KM; Simel DL; Cohen HJ; Crawford J; Currie MS
    J Lab Clin Med; 1990 Jun; 115(6):738-44. PubMed ID: 2366034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
    Schneider R
    Angiology; 1989 Nov; 40(11):987-93. PubMed ID: 2817522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of vitamin E on rheological parameters in high altitude mountaineers.
    Simon-Schnass I; Korniszewski L
    Int J Vitam Nutr Res; 1990; 60(1):26-34. PubMed ID: 2387667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.